Clinical impact of COVID-19 on a French population of spondyloarthritis patients

MeSH terms

• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
• Antirheumatic Agents / therapeutic use*
• Betacoronavirus / isolation & purification
• Biological Products / therapeutic use*
• COVID-19
• Comorbidity
• Coronavirus Infections* / diagnosis
• Coronavirus Infections* / epidemiology
• Coronavirus Infections* / physiopathology
• Female
• France / epidemiology
• Humans
• Male
• Medication Therapy Management / statistics & numerical data
• Middle Aged
• Pandemics*
• Pneumonia, Viral* / diagnosis
• Pneumonia, Viral* / epidemiology
• Pneumonia, Viral* / physiopathology
• SARS-CoV-2
• Spondylarthritis* / diagnosis
• Spondylarthritis* / drug therapy
• Spondylarthritis* / epidemiology
• Symptom Assessment
• Symptom Flare Up